Loading...
Oral and intravenous iron therapy differentially alter the on- and off-tumor microbiota in anemic colorectal cancer patients
Phipps, Oliver Al-Hassi, Hafid Omar Quraishi, Mohammed Nabil Dickson, Edward A Segal, Jonathan Steed, Helen Kumar, Aditi Acheson, Austin G Beggs, Andrew D Brookes, Matthew J
Phipps, Oliver
Al-Hassi, Hafid Omar
Quraishi, Mohammed Nabil
Dickson, Edward A
Segal, Jonathan
Steed, Helen
Kumar, Aditi
Acheson, Austin G
Beggs, Andrew D
Brookes, Matthew J
Editors
Other contributors
Affiliation
Epub Date
Issue Date
2021-03-16
Submitted date
Alternative
Abstract
Iron deficiency anemia is a common complication of colorectal cancer and may require iron therapy. Oral iron can increase the iron available to gut bacteria and may alter the colonic microbiota. We performed an intervention study to compare oral and intravenous iron therapy on the colonic tumor-associated (on-tumor) and paired non-tumor-associated adjacent (off-tumor) microbiota. Anemic patients with colorectal adenocarcinoma received either oral ferrous sulphate (n = 16) or intravenous ferric carboxymaltose (n = 24). On- and off-tumor biopsies were obtained post-surgery and microbial profiling was performed using 16S ribosomal RNA analysis. Off-tumor α- and β-diversity were significantly different between iron treatment groups. No differences in on-tumor diversity were observed. Off-tumor microbiota of oral iron-treated patients showed higher abundances of the orders Clostridiales, Cytophagales, and Anaeroplasmatales compared to intravenous iron-treated patients. The on-tumor microbiota was enriched with the orders Lactobacillales and Alteromonadales in the oral and intravenous iron groups, respectively. The on- and off-tumor microbiota associated with intravenous iron-treated patients infers increased abundances of enzymes involved in iron sequestration and anti-inflammatory/oncogenic metabolite production, compared to oral iron-treated patients. Collectively, this suggests that intravenous iron may be a more appropriate therapy to limit adverse microbial outcomes compared to oral iron.
Citation
Phipps O, Al-Hassi HO, Quraishi MN, Dickson EA, Segal J, Steed H, Kumar A, Acheson AG, Beggs AD, Brookes MJ. (2021) Oral and Intravenous Iron Therapy Differentially Alter the On- and Off-Tumor Microbiota in Anemic Colorectal Cancer Patients. Cancers. 2021; 13(6):1341. https://doi.org/10.3390/cancers13061341
Publisher
Journal
Research Unit
PubMed ID
PubMed Central ID
Embedded videos
Additional Links
Type
Journal article
Language
en
Description
© 2021 The Authors. Published by MDPI. This is an open access article available under a Creative Commons licence.
The published version can be accessed at the following link on the publisher’s website: https://doi.org/10.3390/cancers13061341
Series/Report no.
ISSN
2072-6694
EISSN
ISBN
ISMN
Gov't Doc #
Sponsors
The Ferinject™ used in the original IVICA trial was donated to all study centers, except Nottingham University Hospitals NHS Trust, by Vifor Pharma (Glattbrugg, Switzerland). The study represents independent research funded by the National Institute for Health Research (NIHR) Research for Patient Benefit (RfPB) program (grant number PB-PG-0110-21041).